Walleye Capital LLC Infla Rx N.V. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.83 - $4.48 $970,690 - $2.38 Million	-530,432 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$2.35 - $5.58 $1.25 Million - $2.96 Million	530,432 New	530,432 $2.52 Million
Q2 2020 Aug 14, 2020	SELL	$4.59 - $8.96 $125,674 - $245,324	-27,380 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.65 - $6.08 $72,557 - $166,470	27,380 New	27,380 $104,000

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $76.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.